정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2298 | Recruiting | A Study to Evaluate UB-612 COVID-19 Vaccine in Adolescent, Younger and Elderly Adult Volunteers | COVID-19 | Biological: UB-612 Biological: Placebo |
Phase 2 | United Biomedical Inc., Asia, Vaxxinity, Inc. | INDUSTRY | 3850 | All | 12 Years ~ 85 Years | Changhua Christian Hospital, Changhua, Taiwan Chang-Geng Medical Foundation Kaoshiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan Far Eastern Memorial Hospital, New Taipei City, Taiwan China Medical University Hospital, Taichung, Taiwan Taichung Veterans General Hospital, Taichung, Taiwan National Cheng Kung University Hospital, Tainan, Taiwan Taipei Medical University Hospital, Taipei, Taiwan Taipei Veterans General Hospital, Taipei, Taiwan Tri-Service General Hospital, Taipei, Taiwan Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospital, Taoyuan, Taiwan |
| 2297 | Completed | A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia | COVID-19 Pneumonia | Drug: Tociliuzumab | Phase 2 | Hoffmann-La Roche | INDUSTRY | 97 | All | 18 Years | Mayo Clinic - Arizona, Phoenix, Arizona, United States St. Jude Medical Center, Fullerton, California, United States LAC + USC Medical Center, Los Angeles, California, United States USC Keck Medical Center of USC, Los Angeles, California, United States Norwalk Hospital, Norwalk, Connecticut, United States Medstar Georgetown University Hospital, Washington, District of Columbia, United States Mayo Clinic, Jacksonville, Florida, United States Advocate Christ Medical Center, Oak Lawn, Illinois, United States Advocate Lutheran General Hospital, Park Ridge, Illinois, United States University of Maryland, Baltimore, Maryland, United States Renown Institute for Heart & Vascular Health, Reno, Nevada, United States St Joseph's Regional Medical Center, Wayne, New Jersey, United States SUNY Downstate Medical Center., Brooklyn, New York, United States Jamaica Hospital Medical Center, Jamaica, New York, United States Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States Mercy St. Vincent Medical Center, Toledo, Ohio, United States Lehigh Valley Health Network, Allentown, Pennsylvania, United States Temple University Hospital, Philadelphia, Pennsylvania, United States Allegheny Health Network (Pittsburg PA), Pittsburgh, Pennsylvania, United States Medical University of South Carolina, Charleston, South Carolina, United States Houston Methodist Hospital, Houston, Texas, United States Michael E. DeBakey VA Medical Center, Houston, Texas, United States Houston Methodist Sugar Land Hospital, Sugar Land, Texas, United States |
| 2296 | Completed | A Study to Investigate the Pharmacokinetics, Efficacy and Safety of INM005 in Patients With COVID-19. | Covid19 | Drug: INM005 Drug: Placebo |
Phase 3 | Inmunova S.A. | OTHER | 242 | All | 18 Years ~ 79 Years | Hospital de Cuenca Alta, Canuelas, Buenos Aires, Argentina Hospital Alta Complejidad "El Cruce" Dr. Nestor Carlos Kirchner, Florencio Varela, Buenos Aires, Argentina Hospital Prof. Dr. Bernardo A. Houssay, Florida, Buenos Aires, Argentina Instituto Medico Platense, La Plata, Buenos Aires, Argentina Hospital Italiano de La Plata, La Plata, Buenos Aires, Argentina Hospital Municipal Emilio Zerboni, San Antonio de Areco, Buenos Aires, Argentina Hospital Municipal Dr. Diego E. Thompson, San Martin, Buenos Aires, Argentina Hospital Pablo Soria, San Salvador De Jujuy, Jujuy, Argentina Hospital Provincial Neuquen "Dr. Eduardo Castro Rendon", Neuquen, Neuquen, Argentina Hospital Centro de Salud Zenon J. Santillan, San Miguel De Tucuman, Tucuman, Argentina Sanatorio Guemes, Ciudad Autonoma de Buenos Aires, Argentina Hospital Italiano de Buenos Aires, Ciudad Autonoma de Buenos Aires, Argentina Hospital Muniz, Ciudad Autonoma de Buenos Aires, Argentina Hospital Pirovano, Ciudad Autonoma de Buenos Aires, Argentina Centro Gallego de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina Clinica Adventista Belgrano, Ciudad Autonoma de Buenos Aire, Argentina Clinica Pasteleros, Ciudad Autonoma de Buenos Aire, Argentina Clinica Zabala, Ciudad Autonoma de Buenos Aire, Argentina Fundacion Favaloro, Ciudad Autonoma de Buenos Aire, Argentina Hospital Espanol de Buenos Aires, Ciudad Autonoma de Buenos Aire, Argentina Hospital G. A. Carlos G. Durand, Ciudad Autonoma de Buenos Aire, Argentina Sanatorio Agote, Ciudad Autonoma de Buenos Aire, Argentina Sanatorio Sagrado Corazon, Ciudad Autonoma de Buenos Aire, Argentina |
| 2295 | Active, not recruiting | A Study to Investigate the PK, Safety, and Tolerability of Sotrovimab vs Placebo Administered IV or IM in Japanese and Caucasian Participants | Covid19 | Biological: sotrovimab Other: Placebo to Biologic Biological: sotrovimab Other: Placebo to Biologic |
Phase 1 | Vir Biotechnology, Inc., GlaxoSmithKline | INDUSTRY | 40 | All | 18 Years ~ 65 Years | Investigative Site, Anaheim, California, United States Investigative Site, Glendale, California, United States |
| 2294 | Active, not recruiting | A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 | COVID-19 | Drug: BI 767551 intravenous Drug: BI 767551 inhaled Drug: Placebo intravenous Drug: Placebo inhaled |
Phase 3 | Boehringer Ingelheim | INDUSTRY | 5 | All | 18 Years | Ocean Blue Medical Research Center, Inc., Miami Springs, Florida, United States Pharmatex Research, Amarillo, Texas, United States Advanced Surgeons and Physicians Network, Houston, Texas, United States Crossroads Clinical Research, Victoria, Texas, United States Hospital Clinic de Barcelona, Barcelona, Spain Hospital Universitario Infanta Leonor, Madrid, Spain Hospital Quironsalud Madrid, Pozuelo de Alarcon, Spain |
| 2293 | Withdrawn | A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2 | COVID-19 | Drug: BI 767551 intravenous Drug: BI 767551 inhalation Drug: Placebo intravenous Drug: Placebo inhalation |
Phase 3 | Boehringer Ingelheim | INDUSTRY | 0 | All | 18 Years | |
| 2292 | Recruiting | A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 | Acute Respiratory Distress Syndrome | Drug: Alteplase Procedure: Standard of care |
Phase 3 | Boehringer Ingelheim | INDUSTRY | 320 | All | 18 Years | Wiener Gesundheitsverbund Klinik Favoriten, Vienna, Austria ULB Hopital Erasme, Bruxelles, Belgium Hospital Alemao Oswaldo Cruz, Sao Paulo, Brazil Hvidovre Hospital, Hvidovre, Denmark HOP Europeen G. Pompidou, Paris cedex 15, France Universitatsklinikum Heidelberg, Heidelberg, Germany Istituto Clinico Humanitas, Rozzano (MI), Italy Gelre Ziekenhuizen Apeldoorn, Apeldoorn, Netherlands CHLO, EPE - Hospital Egas Moniz, Lisboa, Portugal City Clinical Emergency Hospital, Ryazan, Russian Federation Hospital Vall d'Hebron, Barcelona, Spain |
